Acute right ventricular failure in a patient with nonischemic cardiogenic shock on left‐sided mechanical circulatory support

Routh, Shuvodra; Fabrizio, Carly; Sciortino, Christopher M.; Kilic, Arman; Toma, Catalin; Ramanan, Raj; Fowler, Jeffrey; Randhawa, Parmjeet; Hickey, Gavin

doi:10.1111/jocs.15756

Cited by 4 publications

(3 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Once the patient's hypoxia resolved, the ML was removed from the circuit, leaving the ProtekDuo® as a traditional percutaneous, temporary RVAD in a (dl)VxP configuration. The patient underwent heart transplantation and was discharged from the hospital [51].…”

Section: Protekduo® Cannula and Impella 50 And 55mentioning

confidence: 99%

Adaptive ECMO Therapeutics: The Integral Role of the ProtekDuo® Cannula

Brewer,

Dacey,

O. Maybauer

2024

Evolving Therapies and Technologies in Extracorporeal Membrane Oxygenation [Working Title]

View full text Add to dashboard Cite

This chapter provides an in-depth analysis of the ProtekDuo® (LivaNova, London) dual-lumen cannula’s application in extracorporeal membrane oxygenation (ECMO), focusing on the procedural techniques of cannulation, weaning, and decannulation. The discussion will provide the step-by-step methodologies for inserting and removing the cannula, drawing from current clinical practices. Further, the chapter will explore the range of ECMO configurations that the ProtekDuo® cannula enables. It will examine how these configurations can be tailored to the evolving clinical requirements of patients, thereby enhancing the adaptability and effectiveness of ECMO therapy. This analysis will be anchored in the latest literature, providing a contemporary overview of patient outcomes and current practices. Lastly, the chapter will project into the future of the cannula technology for venopulmonary (VP) ECMO and other configurations. It will review ongoing research and development efforts, speculate on potential technological breakthroughs, and discuss the implication of these innovations for clinical practice. This forward-looking perspective will aim to inform and inspire continued advancement in ECMO therapy and technology.

show abstract

Section: Protekduo® Cannula and Impella 50 And 55mentioning

confidence: 99%

Adaptive ECMO Therapeutics: The Integral Role of the ProtekDuo® Cannula

Brewer,

Dacey,

O. Maybauer

2024

Evolving Therapies and Technologies in Extracorporeal Membrane Oxygenation [Working Title]

View full text Add to dashboard Cite

show abstract

“…Acute RV failure after LVAD implantation is reported to occur in up to 40% of cases [26,[41][42][43][44]. Multiple causes, either alone or in combination, including unmasking of chronic RV dysfunction once RV preload increases, distortion of RV geometry due to bowing of the intraventricular septum toward the LV due Perspective Chapter: The ProtekDuo® Cannula for Acute Mechanical Circulatory Support DOI: http://dx.doi.org/10.5772/intechopen.111537 to mechanical LV unloading, ventricular dysrhythmias, and embolic phenomenon to the coronary or pulmonary circulation are thought to precipitate RV failure [45]. Patients with LVADs who develop additional acute RV failure and require biventricular support have a high mortality [26].…”

Section: Protekduo® For Biventricular Failurementioning

confidence: 99%

“…Routh and coauthors reported a case of a 61-year old man with inotrope-dependent nonischemic cardiomyopathy who developed acute cardiogenic shock initially treated with Impella 5.5. The patient subsequently developed acute RV failure and a ProtekDuo® cannula was placed, allowing for biventricular support [45]. Ramamurthi et al reported a case series of six patients who underwent carotid placement of an Impella 5.5 for left ventricular support.…”

Section: Protekduo® With Temporary Lvadsmentioning

confidence: 99%

Perspective Chapter: The ProtekDuo® Cannula for Acute Mechanical Circulatory Support

Brewer¹,

Sharif²,

Maybauer³

2023

Ventricular Assist Devices - Advances and Applications in Heart Failure

View full text Add to dashboard Cite

The ProtekDuo® is a dual lumen cannula that can be used in numerous configurations to treat cardiogenic shock and hypotension. Its default function is as a temporary percutaneous right ventricular assist device (RVAD) system, however, other configurations both alone and with other mechanical circulatory support (MCS) devices have evolved. In addition to its use as a component of a ventricular assist device (VAD), it can be used as a cannula for extracorporeal membrane oxygenation (ECMO) and may serve as double lumen drainage cannula on cardiopulmonary bypass (CPB). The role of the cannula in ECMO has been described in multiple configurations including traditional veno-pulmonary (V-P) or “oxygenated RVAD” (oxyRVAD), veno-venopulmonary (V-VP), or venopulmonary-arterial (VP-A). This book chapter summarizes various configurations and technical aspects of the ProtekDuo(R) cannula in the management of hypotension and cardiogenic shock.

show abstract